Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to $1.0 million.

  • Ultralife's Depreciation & Amortization (CF) rose 3176.47% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 2514.83%. This contributed to the annual value of $3.1 million for FY2024, which is 2009.72% down from last year.
  • Ultralife's Depreciation & Amortization (CF) amounted to $1.0 million in Q3 2025, which was up 3176.47% from $1.0 million recorded in Q2 2025.
  • Ultralife's Depreciation & Amortization (CF)'s 5-year high stood at $1.0 million during Q2 2025, with a 5-year trough of $700000.0 in Q3 2021.
  • Over the past 4 years, Ultralife's median Depreciation & Amortization (CF) value was $761000.0 (recorded in 2023), while the average stood at $805214.3.
  • As far as peak fluctuations go, Ultralife's Depreciation & Amortization (CF) tumbled by 288.71% in 2024, and later skyrocketed by 3176.47% in 2025.
  • Over the past 4 years, Ultralife's Depreciation & Amortization (CF) (Quarter) stood at $700000.0 in 2021, then grew by 5.71% to $740000.0 in 2023, then rose by 12.3% to $831000.0 in 2024, then increased by 21.3% to $1.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $1.0 million for Q3 2025, versus $1.0 million for Q2 2025 and $950000.0 for Q1 2025.